Association between inflammatory bowel disease and frailty: a two-sample Mendelian randomization study

Jingyi Feng,Xi Chen,Wenjing Cai,Xueying Zhou,Xuefang Zhang

DOI: https://doi.org/10.1007/s40520-023-02688-1

2024-02-08

Aging Clinical and Experimental Research

Abstract:An association has been identified between inflammatory bowel disease (IBD) and frailty; however, the causal nature of this connection remains uncertain. We consequently conducted a two-sample Mendelian randomization (MR) analysis to explore this particular association.

geriatrics & gerontology,gerontology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the causal relationship between inflammatory bowel disease (IBD) and frailty. Specifically, the author explored whether IBD (including Crohn's disease (CD) and ulcerative colitis (UC)) can lead to frailty and whether frailty can lead to the development of IBD through two - sample Mendelian randomization (MR) analysis method.

### Background
- **Inflammatory bowel disease (IBD)**: IBD is a chronic, immune - mediated non - specific inflammatory disease, mainly including Crohn's disease (CD) and ulcerative colitis (UC).
- **Frailty**: Frailty is a state of reduced multi - system physiological reserve and decreased stress resistance, which is common in the elderly population.

### Research objectives
- **Main objective**: To explore the causal relationship between IBD and frailty through two - sample Mendelian randomization analysis.
- **Specific questions**:
- Does IBD increase the risk of frailty?
- Does frailty increase the risk of IBD?

### Methods
- **Data sources**: Obtain relevant data on IBD, CD, UC and frailty from the published genome - wide association study (GWAS) databases.
- **Analysis methods**: Use statistical methods such as inverse - variance weighted (IVW), weighted median and MR - Egger regression for analysis.

### Results
- **The impact of IBD on frailty**:
- Overall, the genetically increased frailty risk is associated with an increased IBD risk (OR: 1.015, 95% CI 1.005–1.025, P = 0.004).
- Specifically for the subtypes of IBD, both Crohn's disease (CD) and ulcerative colitis (UC) show a trend of increasing the frailty risk (CD: OR: 1.018, 95% CI 1.010–1.027, P < 0.05; UC: OR = 1.016, 95% CI 1.005–1.027, P < 0.05).
- **The impact of frailty on IBD**:
- Reverse MR analysis did not find a causal impact of frailty on the development of IBD (OR: 0.777, 95% CI 0.173–3.488, P = 0.742).

### Conclusions
- **Main conclusion**: IBD (including CD and UC) may increase the risk of frailty, but frailty has no significant causal impact on the development of IBD.
- **Clinical significance**: Clinicians should pay attention to the early frailty assessment of IBD patients and take corresponding preventive and management measures.

### Discussion
- **Mechanism explanation**:
- Chronic inflammatory response plays an important role in both IBD and frailty.
- Sarcopenia is considered a precursor of frailty and is related to intestinal malabsorption in IBD patients.
- **Research limitations**:
- The data are limited to the European population, which may limit the universality of the results.
- There is heterogeneity, which may affect the reliability of the results.

### Future directions
- Further explore the detailed mechanisms of the association between IBD and frailty to guide clinical prevention and treatment.